SCHEMBL20714947

SCHEMBL20714947

c1ccc(-c2nc(-c3ccccc3)c3c(n2)oc2ccc(-c4cccc(-n5c6ccc(-c7ccc8oc9ccccc9c8c7)cc6c6cc(-c7ccc8c(c7)c7ccccc7n8-c7ccccc7)ccc65)c4)cc23)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 5/20 0.36
LMNA P02545 2/20 0.36
ALDH1A1 P00352 2/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2C9 P11712 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
L3MBTL1 Q9Y468 2/20 0.33
KDM4E B2RXH2 1/20 0.33
ATM Q13315 1/20 0.33
HPGD P15428 2/20 0.32
NPC1 O15118 1/20 0.32
HTT P42858 1/20 0.32
RAB9A P51151 1/20 0.32
PTGER4 P35408 1/20 0.32
CHEK2 O96017 1/20 0.32
NPY5R Q15761 1/20 0.32
PLA2G2A P14555 2/20 0.31
PLA2G4A P47712 2/20 0.31
PLA2G10 O15496 1/20 0.31
MEN1 O00255 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20030036 0.95 ATM (0.37) SMN1; SMN2LMNAALDH1A1CYP1A2CYP2C9
SCHEMBL20715259 0.94 CHEK2 (0.33) SMN1; SMN2LMNAALDH1A1CYP1A2CYP2C9
SCHEMBL24388302 0.93 L3MBTL1 (0.37) SMN1; SMN2LMNAALDH1A1CYP1A2CYP2C9
SCHEMBL20029876 0.93 ATM (0.38) SMN1; SMN2LMNAALDH1A1CYP1A2CYP2C9
SCHEMBL20029928 0.93 ATM (0.38) SMN1; SMN2LMNAALDH1A1CYP1A2CYP2C9
SCHEMBL20024779 0.93 SMN1; SMN2 (0.33) SMN1; SMN2LMNAALDH1A1CYP1A2CYP2C9
SCHEMBL24388314 0.92 L3MBTL1 (0.36) SMN1; SMN2LMNAALDH1A1CYP1A2CYP2C9
SCHEMBL18273486 0.92 SMN1; SMN2 (0.36) SMN1; SMN2LMNAALDH1A1CYP1A2CYP2C9
SCHEMBL20029870 0.92 SMN1; SMN2 (0.36) SMN1; SMN2LMNAALDH1A1CYP1A2CYP2C9
SCHEMBL18273519 0.92 SMN1; SMN2 (0.35) SMN1; SMN2LMNAALDH1A1CYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190044071-A1 CARBAZOLES WITH TWO DIBENZOFURAN OR DIBENZOTHIOPHENE SUBSTITUENTS MERCK PATENT GMBH (DE) 2019-02-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190044071-A1 CARBAZOLES WITH TWO DIBENZOFURAN OR DIBENZOTHIOPHENE SUBSTITUENTS BRD3, BRPF3, DDT SMN1; SMN2 4384/4885LMNA 4865/4885ALDH1A1 610/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.